© 2025 Historical Returns. All rights reserved.

Historical Returns of Cipla Limited

From 1996 to 2024 (28 years), the stock price grew by 17,834.32%. Dividends were issued 29 times and stock splits occurred 3 times during this period.

Find Out How Much Your Investment in Cipla Limited Could Have Grown.

Invested

Bought

Investment Period
Start Date
End Date
Cipla Limited data starting From 1, 1996

Results

Capital Growth

Between , your total capital would have grown XXXX.

Dividends

You would have earned XXXX in dividends.

Stock Splits

Your total number of shares after stock splits and bonus shares would have grown from XXXX.

Cipla Limited

Cipla Limited is a global pharmaceutical company and a leader in the healthcare industry, known for its commitment to providing affordable and high-quality medicines. Established in 1935, Cipla has played a pivotal role in improving access to healthcare in India and over 80 countries worldwide.

The company’s diverse product portfolio includes medications for respiratory, cardiovascular, diabetes, oncology, and HIV/AIDS, among other therapeutic areas. Cipla is recognized for its pioneering work in generic medicines, making essential drugs more accessible to patients globally.

With a strong focus on innovation and research, Cipla develops advanced therapies and drug delivery systems to address complex medical needs. The company is also a leader in sustainability, adopting environmentally friendly manufacturing practices and supporting community health initiatives.

As a trusted name in the pharmaceutical industry, Cipla Limited continues to deliver on its promise of ‘Caring for Life’ by improving patient outcomes and contributing to global health advancements.